|
WO2020264337A1
|
|
Child-resistant dispensers for thin strip medications
|
|
US2020383924A1
|
|
Modified release formulations and uses thereof
|
|
WO2020247603A1
|
|
Modified release formulations and uses thereof
|
|
US2020290987A1
|
|
Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
|
|
WO2020185993A1
|
|
Child resistant peel pouch
|
|
WO2020160005A1
|
|
Methods of treating a patient having parkinson's disease
|
|
US2020179336A1
|
|
Methods of treating neurological and psychiatric disorders
|
|
WO2020092496A1
|
|
Methods of treating central nervous system disorders
|
|
WO2020041683A2
|
|
Acid addition salts of apomorphine, pharmaceutical compositions containing the same, and methods of using the same
|
|
WO2019236808A1
|
|
Salts of a oxazino[4,3-b]indazole derivative and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
|
|
US2020330719A1
|
|
Nebulizer monitoring device, system and method
|
|
WO2020219012A1
|
|
Nebulizer monitoring device, system and method cross-reference to related application
|
|
SG11202007823PA
|
|
Salts, crystal forms, and production methods thereof
|
|
US2021008030A1
|
|
Methods of treating social function disorders
|
|
US2020405867A1
|
|
Oral dosage forms
|
|
SG11202005016SA
|
|
Nonracemic mixtures and uses thereof
|
|
WO2019113084A1
|
|
Crystal forms and production methods thereof
|
|
KR20200036008A
|
|
Isocroman compounds and uses thereof
|
|
KR20190129035A
|
|
Treatment of Schizophrenia
|
|
CN110352187A
|
|
Acrylamide method
|
